Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO‐incompatible liver transplant

Abstract

AbstractIntroductionLiver transplant is a life‐saving treatment, but due to the limited availability of suitable liver donors, ABO‐incompatible liver transplants (ABOi‐LT) are conducted to increase the availability of liver donors. Perioperative desensitization for ABOi‐LT is an established strategy to circumvent the risk of graft rejection. A single prolonged session can be performed to achieve the desired titers to avoid using multiple immunoadsorption (IA) columns or off‐label reuse of single‐use columns. This study retrospectively assessed the effectiveness of a single prolonged plasmapheresis session using IA as a desensitization strategy in live donor liver transplant (LDLT).Materials and methodsThis retrospective observational study conducted at a center for liver diseases in North India on six ABOi‐LDLT patients who underwent single prolonged IA sessions in the perioperative period from January 2018 to June 2021.ResultsMedian baseline titer in patients was 320 (64, 1024). The median plasma volume adsorbed was 7.5 volumes (4, 8) per procedure, with a mean procedure time of 600 min (310‐753). The reduction in titer ranged from 4 log to 7 log reduction per procedure. Two patients developed transient hypotension during the procedure, which was managed successfully. The median duration of pre‐transplant hospital stay was 1.5 days (1, 3).ConclusionDesensitization therapy helps overcome the ABO barrier and decreases the waiting period before a transplant when ABO identical donors are unavailable. A single prolonged IA session reduces the cost of additional IA columns and hospital stay, thus making it a cost‐effective approach to desensitization.